Lubner et al. reported one of the first studies evaluating the clinical utility of radiomic features in patients with CRLM [110] The authors examined CT scans in 77 patients with a single untreated CRLM and noted an association between the radiomic features and tumor grade, KRAS mutation, and overall survival. This evidence concerns the gene KRAS and neoplasm.